Cardiac tumor recurrence after orthotopic heart transplantation in primary cardiac lymphoma

被引:0
作者
Wu, Nana [1 ,2 ,3 ]
Li, Yan [1 ,2 ]
Liu, Zhe [1 ,2 ]
Henderson, Fraser C. [4 ]
Chen, Nianyong [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp, Ctr Canc, Dept Radiat Oncol, 37 Guoxuexiang, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, 37 Guoxuexiang, Chengdu 610041, Sichuan, Peoples R China
[3] Chengdu First Peoples Hosp, Dept Oncol, Chengdu 610041, Sichuan, Peoples R China
[4] Med Univ S Carolina, Charleston, SC 29425 USA
关键词
Primary cardiac lymphoma; chemotherapy; radiotherapy; orthotopic heart transplantation; CELL LYMPHOMA;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Primary cardiac lymphoma is a rare malignancy. It is difficult to diagnose, and there is no standard mode of treatment, surgical resection is rarely performed. The prognosis is poor, because of the advanced stage of myocardial involvement at the time of presentation. We report a rare case of PCL diagnosed as DLBCL treated with orthotopic heart transplantation and 4 cycles of chemotherapy with R-COP. The patient achieved a complete response (CR), but suffered from a pulmonary fungal infection. A tumor occurrence was occurred in the mediastina and the transplanted heart, due to 2 months suspension of chemotherapy for the infection. Subsequently, the patient received a mediastinal intensity-modulated radiation therapy (IMRT) of 20 Gy in 11 fractions and a second-line chemotherapy with GEMOX with a partial response (PR). However, the patient finally died of tumor progression (in the mediastina, the neck, the thorax, and the abdomen) and serious fungal infection of lungs and survived for 11 months after diagnosis.
引用
收藏
页码:324 / 328
页数:5
相关论文
共 13 条
[1]  
BLACKLEDGE G, 1979, CLIN ONCOL, V5, P209
[2]  
Chim CS, 1979, AM J HEMATOL, V5, P209
[3]   The successful treatment of primary cardiac lymphoma with a dose-dense schedule of rituximab plus CHOP [J].
Dawson, MA ;
Mariani, J ;
Taylor, A ;
Koulouris, G ;
Avery, S .
ANNALS OF ONCOLOGY, 2006, 17 (01)
[4]   Primary cardiac cytotoxic T-cell lymphoma presenting with neurological deficits: a case report [J].
Deepti, Akkihebbal N. ;
Noone, Mohan L. ;
Mahadevan, Anita ;
Naresh, Kikkeri N. ;
Yasha, Tagadur C. ;
Satishchandra, Parthasarathy ;
Muthane, Uday B. ;
Shankar, Susarla K. .
CARDIOVASCULAR PATHOLOGY, 2008, 17 (05) :334-338
[5]   NT-proBNP: A cardiac biomarker to assess prognosis in non-Hodgkin lymphoma [J].
Gimeno, Eva ;
Gomez, Miquel ;
Ramon Gonzalez, Juan ;
Comin, Josep ;
Alvarez-Larran, Alberto ;
Sanchez-Gonzalez, Blanca ;
Molina, Lluis ;
Domingo-Domenech, Eva ;
Garcia-Pallarols, Francesc ;
Pedro, Carmen ;
Abella, Eugenia ;
Vilaplanah, Carles ;
de Sanjose, Silvia ;
Besses, Carlos ;
Salar, Antonio .
LEUKEMIA RESEARCH, 2011, 35 (06) :715-720
[6]   Clinical perspectives of primary cardiac lymphoma [J].
Gowda, RM ;
Khan, IA .
ANGIOLOGY, 2003, 54 (05) :599-604
[7]   Cardiac effects within 3 months of BEAC high-dose therapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation [J].
Kuittinen, T. ;
Jantunen, E. ;
Vanninen, E. ;
Mussalo, H. ;
Vuolteenaho, O. ;
Ala-Kopsala, M. ;
Nousiainen, T. ;
Hartikainen, J. .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 77 (02) :120-127
[8]  
Mejhert M, 2000, SCAND CARDIOVASC J, V34, P606
[9]   Primary cardiac lymphoma [J].
Miguel, Carlos E. ;
Bestetti, Reinaldo B. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 149 (03) :358-363
[10]   CARDIAC LYMPHOMA - AN UNUSUAL CASE OF MYOCARDIAL PERFORATION-CLINICAL, ECHOCARDIOGRAPHIC, HEMODYNAMIC AND PATHOLOGICAL FEATURES [J].
MOLAJO, AO ;
MCWILLIAM, L ;
WARD, C ;
RAHMAN, A .
EUROPEAN HEART JOURNAL, 1987, 8 (05) :549-552